Quick Takeaways
- Alyeska Investment Group, L.P. filed SCHEDULE 13G for IN8BIO, INC. Common Stock, $0.0001 par value per share (INAB).
- Disclosed ownership: 9.9%.
- Date of event: 31 Dec 2024.
Alyeska Investment Group, L.P. - 31 Dec 2024 SCHEDULE 13G Report for IN8BIO, INC. Common Stock, $0.0001 par value per share (INAB)
- Filing Manager
- Alyeska Investment Group, L.P.
- Reporting Manager
- Alyeska Investment Group, L.P.
- Symbol
- INAB
- Shares outstanding
- 73,142,182 shares
- Disclosed Ownership
- 7,241,076 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Feb 2025, 16:29:19 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Alyeska Investment Group, L.P. disclosed 9.9% ownership in IN8BIO, INC. Common Stock, $0.0001 par value per share (INAB) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 16:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 9.9% | 7,241,076 | 0 | 7,241,076 | Jason Bragg | Jason Bragg | Chief Financial Officer | |
| Alyeska Fund GP, LLC | 9.9% | 7,241,076 | 0 | 7,241,076 | Jason Bragg | Jason Bragg | Chief Financial Officer | |
| Anand Parekh | 9.9% | 7,241,076 | 0 | 7,241,076 | Anand Parekh | Anand Parekh | Self |